Cochrane · systematic review · CD008382

Very early discharge versus early discharge versus non‐early discharge in children with cancer and febrile neutropenia

Loeffen, EAH, te Poele, EM, Tissing, WJE, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

Childhood CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
15
current version
GRADE rated
12
No studies
3
Included studies
NR
No studies 3 · 20%Ungraded 0 · 0%Very low 0 · 0%Low 12 · 80%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Early discharge versus non‐early discharge for children with cancer and febrile neutropenia at low risk for invasive bacterial infection

Population: children with cancer
7 questions
OutcomeEffectEvidenceStatus / GRADE
Treatment failure; rehospitalization or adjustment of antimicrobial treatment, or both in number of episodes
Early discharge vs non‐early discharge
RR 0.91 [0.24, 3.5]NRLow
Downgraded: risk of bias, imprecision
Treatment failure; death
Early discharge vs non‐early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Costs in USD
Early discharge vs non‐early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Duration of total antimicrobial treatment in days
Early discharge vs non‐early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Duration of intravenous antimicrobial treatment in days
Early discharge vs non‐early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Duration of oral antimicrobial treatment in days
Early discharge vs non‐early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Quality of life
Early discharge vs non‐early discharge
no estimate extractedNRNo studies

Very early discharge versus early discharge for children with cancer and febrile neutropenia at low risk for invasive bacterial infection

Population: children with cancer
8 questions
OutcomeEffectEvidenceStatus / GRADE
Treatment failure; rehospitalization or adjustment of antimicrobial treatment (or both) in number of episodes
Very early discharge vs early discharge
RR 0.54 [0.15, 1.89]NRLow
Downgraded: risk of bias, imprecision
Treatment failure; rehospitalization or adjustment of antimicrobial treatment (or both), only first episode in number of participants
Very early discharge vs early discharge
RR 0.32 [0.07, 1.4]NRLow
Downgraded: risk of bias, imprecision
Treatment failure; death
Very early discharge vs early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Costs
Very early discharge vs early discharge
no estimate extractedNRNo studies
Duration of total antimicrobial treatment
Very early discharge vs early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Duration of intravenous antimicrobial treatment
Very early discharge vs early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Duration of oral antimicrobial treatment
Very early discharge vs early discharge
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Quality of life
Very early discharge vs early discharge
no estimate extractedNRNo studies